(Q72368992)
Statements
Phase I study of RP 49532A, a new protein-synthesis inhibitor, in patients with advanced refractory solid tumors (English)
G Catimel
R Coquard
J P Guastalla
Y Merrouche
N Le Bail
M K Alakl
A Dumortier
M Foy
1 reference